
Drug development typically follows a scale-up of product
requirements as the drug candidate develops from pre-clinical
to clinical and finally, to commercial requirements
post-marketing approval. The RollerCell 40T unit provides
unique flexibility to expand capacity while maintaining
high utilization. As your product requirements increase,
we simply commit more units to your production. This
flexibility avoids comprising utilization and efficiency
in the early stages of your product requirements, and
similarly, provides an orderly increase in production
without disrupting product output as product requirements
reach high volume levels associated with commercialization.
|